Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study

被引：0
|
作者：
Luca Triggiani
Filippo Alongi
Michela Buglione
Beatrice Detti
Riccardo Santoni
Alessio Bruni
Ernesto Maranzano
Frank Lohr
Rolando D’Angelillo
Alessandro Magli
Alberto Bonetta
Rosario Mazzola
Nadia Pasinetti
Giulio Francolini
Gianluca Ingrosso
Fabio Trippa
Sergio Fersino
Paolo Borghetti
Paolo Ghirardelli
Stefano Maria Magrini
机构：
[1] University and Spedali Civili Hospital,Department of Radiation Oncology
[2] Sacro Cuore Don Calabria Cancer Care Center,Department of Radiation Oncology
[3] A.O.U Careggi,Department of Radiation Oncology
[4] University of Florence,Department of Radiation Oncology
[5] Policlinico Tor Vergata,Department of Radiation Oncology
[6] University of Rome,Department of Radiation Oncology
[7] AOU Policlinico Modena,Department of Radiation Oncology
[8] ‘S. Maria’ Hospital,Department of Radiation Oncology
[9] Campus Biomedico University,Department of Radiation Oncology
[10] ‘Santa Maria della Misericordia’ Hospital,undefined
[11] Cremona Hospital,undefined
来源：
British Journal of Cancer | 2017年 / 116卷
关键词：
oligometastases; prostate cancer; SBRT; SABR; radiotherapy; androgen deprivation therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1520 / 1525
页数：5
相关论文
共 50 条
  • [41] Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castrationresistant prostate cancer patients - A closer inspection will improve your vision
    Baron, D.
    Pasquier, D.
    Pace-Loscos, T.
    Vandendorpe, B.
    Schiappa, R.
    Ortholan, C.
    Hannoun-Levi, J. M.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 46
  • [42] Stereotactic body radiotherapy in bone oligometastatic prostate cancer: a retrospective study
    Trippa, F.
    Costantini, S.
    Terenzi, S.
    Ingrosso, G.
    Scoccianti, S.
    Di Marzo, A.
    Detti, B.
    Triggiani, L.
    Borghesi, S.
    Bardoscia, L.
    Puccini, P.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1236 - S1236
  • [43] Stereotactic body radiotherapy (SBRT) and concomitant systemic therapy in oligoprogressive breast cancer patients
    Luca Nicosia
    Vanessa Figlia
    Nicola Ricottone
    Francesco Cuccia
    Rosario Mazzola
    Niccolò Giaj-Levra
    Francesco Ricchetti
    Michele Rigo
    Fatemeh Jafari
    Stefano Maria Magrini
    Andrea Girlando
    Filippo Alongi
    Clinical & Experimental Metastasis, 2022, 39 : 581 - 588
  • [44] Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective Studies
    Marvaso, Giulia
    Volpe, Stefania
    Pepa, Matteo
    Augugliaro, Matteo
    Corrao, Giulia
    Biffi, Annalisa
    Zaffaroni, Mattia
    Bergamaschi, Luca
    Fauci, Francesco Maria La
    Mistretta, Francesco Alessandro
    Luzzago, Stefano
    Cattani, Federica
    Musi, Gennaro
    Petralia, Giuseppe
    Pravettoni, Gabriella
    De Cobelli, Ottavio
    Orecchia, Roberto
    Jereczek-Fossa, Barbara Alicja
    EUROPEAN UROLOGY OPEN SCIENCE, 2021, 27 : 19 - 28
  • [45] Stereotactic Body Radiotherapy for Oligoprogressive Lesions in Metastatic Castration-Resistant Prostate Cancer Patients During Abiraterone/Enzalutamide Treatment
    Onal, C.
    Kose, F.
    Ozyigit, G.
    Aksoy, S.
    Oymak, E.
    Muallaoglu, S.
    Guler, O. C.
    Tilki, B.
    Hurmuz, P.
    Akyol, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E289 - E289
  • [46] Predictive factors for response to salvage stereotactic body radiotherapy in oligorecurrent prostate cancer limited to lymph nodes: a single institution experience
    Oehler, Christoph
    Zimmermann, Michel
    Adam, Lukas
    Curschmann, Juergen
    Sumila, Marcin
    Strebel, Raeto T.
    Cathomas, Richard
    Li, Qiyu
    Schneider, Uwe
    Zwahlen, Daniel R.
    BMC UROLOGY, 2019, 19 (01)
  • [47] Predictive factors for response to salvage stereotactic body radiotherapy in oligorecurrent prostate cancer limited to lymph nodes: a single institution experience
    Christoph Oehler
    Michel Zimmermann
    Lukas Adam
    Juergen Curschmann
    Marcin Sumila
    Räto T. Strebel
    Richard Cathomas
    Qiyu Li
    Uwe Schneider
    Daniel R. Zwahlen
    BMC Urology, 19
  • [48] Stereotactic body radiotherapy for localized prostate cancer-5-year efficacy results
    Vuolukka, Kristiina
    Auvinen, Paivi
    Tiainen, Erno
    Palmgren, Jan-Erik
    Heikkila, Janne
    Seppala, Jan
    Aaltomaa, Sirpa
    Kataja, Vesa
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [49] Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results
    Kristiina Vuolukka
    Päivi Auvinen
    Erno Tiainen
    Jan-Erik Palmgren
    Janne Heikkilä
    Jan Seppälä
    Sirpa Aaltomaa
    Vesa Kataja
    Radiation Oncology, 15
  • [50] Quality of Life and Efficacy for Stereotactic Body Radiotherapy for Treatment of Organ Confined Prostate Cancer
    Katz, A. J.
    Santoro, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S58 - S58
12345